A Pilot Study of Adjunctive Aspirin for the Treatment of HIV Negative Adults With Tuberculous Meningitis

NCT02237365 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Tuberculous Meningitis

Interventions

DRUG: 81mg aspirin
DRUG: 1000mg aspirin
DRUG: Placebo

Sponsor

Oxford University Clinical Research Unit, Vietnam

Collaborators

[object Object]